Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Prostate cancer | R-HSA-2990872 | map05215 | iopamidol | 31378 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | iopamidol | 31378 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | iopamidol | 31378 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | iopamidol | 31378 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | iopamidol | 31378 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | iopamidol | 31378 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | iopamidol | 31378 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | iopamidol | 31378 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | iopamidol | 31378 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | iopamidol | 31378 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | iopamidol | 31378 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | methazolamide | 21138 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | methazolamide | 21138 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | cromoglicic acid | 2882 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | cromoglicic acid | 2882 | drug-path |
| Shigellosis | 0 | map05131 | cromoglicic acid | 2882 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | cromoglicic acid | 2882 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | cromoglicic acid | 2882 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | cromoglicic acid | 2882 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | levomepromazine | 65863 | drug-path |